Integration and analysis of heterogeneous data in molecular medicine research - When
- Prosjektnummer
- 46056635
- Ansvarlig person
- Morten Rye
- Institusjon
- NTNU, IKOM
- Prosjektkategori
- Forskerstipend 2012
- Helsekategori
- Cancer
- Forskningsaktivitet
- 1. Underpinning, 4. Detection and Diagnosis
SFRP4 gene expression is increased in aggressive prostate cancer.
Sci Rep 2017 Oct 27;7(1):14276. Epub 2017 okt 27
PMID: 29079735
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer.
PLoS One 2016;11(4):e0153727. Epub 2016 apr 21
PMID: 27100877
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer.
Oncotarget 2016 Jul 05;7(27):42071-42085.
PMID: 27276682
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.
J Transl Med 2016 Mar 15;14():71. Epub 2016 mar 15
PMID: 26975394
A novel non-canonical Wnt signature for prostate cancer aggressiveness.
Oncotarget 2017 Feb 07;8(6):9572-9586.
PMID: 28030815
Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer.
BMC Med Genomics 2014;7():50. Epub 2014 aug 12
PMID: 25115192
APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer
Oncotarget, 2017, In Press
- Morten Beck Rye Prosjektleder
- Kjersti Rise Doktorgradsstipendiat
- Finn Sverre Drabløs Prosjektdeltaker
- Tone Frost Bathen Prosjektdeltaker
- Helena Bertilsson Prosjektdeltaker
- May-Britt Tessem Prosjektdeltaker
- Anders Angelsen Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU